Health Policy Update | Exclusive News and Resources for GIH Partners

In collaboration with:

 

September 3, 2025

Leavitt Partners | An HMA Company (logo)
 

Spotlight

Congress is returning to DC this week after being in recess for the month of August. The focus will be on funding the government beyond September 30, which is when fiscal year (FY) 2025 ends. Congressional appropriations committees have started the process of voting on appropriations legislation, and since appropriations bills in the Senate require 60 votes, Congress will have to find bipartisan agreement on a path forward. If Congress cannot agree on an FY 2026 appropriations bill, in order to avoid a shutdown, they could pass a continuing resolution (CR) which largely continues funding the government at current funding levels.

 

Congressional and Administration Updates

On August 27, the White House released a statement that Dr. Susan Monarez was terminated from her role as director of the Centers for Disease Control and Prevention (CDC) after reportedly being asked to resign by Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., and refusing. The CDC was under her leadership for 28 days. Several other top CDC career officials resigned the same day, which has raised significant concern from members of Congress and stakeholders regarding the decisions and recommendations being made on scientific issues, particularly vaccine recommendations.

  • The departures also leave the agency chiefly responsible for public health without permanent leadership after being significantly affected by Reductions in Force (RIFs) and the recent attack on the CDC in which one person was killed. Jim O’Neill, who is currently the HHS Deputy Secretary, has been named the acting director of CDC. The CDC Director is a Senate confirmed position, so a new permanent director cannot be installed without action by Congress.
     
  • Key Senators have called for oversight of HHS following the announcements, and the top Democrat on the Senate Appropriations Committee called for Secretary Kennedy to be dismissed from his role. Secretary Kennedy is scheduled to testify before the Senate Finance Committee on Thursday, September 4. The hearing is titled, “The President’s 2026 Health Care Agenda,” and, although it is not specifically related to the recent events at CDC, Senators on both sides of the aisle will likely raise questions about the recent departures and the future of the agency.


On August 19, the Centers for Medicare and Medicaid Services (CMS) announced an oversight initiative to remove individual enrollees who do not meet citizenship requirements from the Medicaid and CHIP programs. As part of the initiative, CMS will begin sending states monthly enrollment reports that flag individuals whose citizenship or immigration status cannot be confirmed through federal databases, including DHS’ Systematic Alien Verification for Entitlements (SAVE) system. States are expected to review flagged cases, request additional documentation where needed, and take actions, including coverage adjustments when eligibility cannot be verified. Funders should be aware and ready to assist partners helping eligible immigrants retain Medicaid and CHIP coverage. The nonpartisan Congressional Research Service notes the following types of noncitizens may be eligible for Medicaid: “lawful permanent residents (LPRs), refugees, aliens granted parole for at least one year, aliens granted asylum or related relief, certain abused spouses and children, Cuban-Haitian entrants, and Citizens of the Freely Associated States (FAS) residing in the U.S. states and territories.”
 

HHS also moved to revoke the remaining emergency use authorizations (EUAs) for the COVID-19 vaccine, issuing market authorization for updated boosters only for adults 65 and older and individuals under the age of 65 who are at increased risk for severe COVID-19. Several public health officials, including Dr. Paul Offit, a member of the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee, and Dr. Jerome Adams, the Surgeon General under the first Trump Administration, expressed concern that this action from FDA will restrict access to the COVID-19 vaccine. The revocation of the EUAs as well as other recent actions related to vaccines could mean that COVID-19 vaccine access at pharmacies will be limited and/or payment will be required, where previously they were available with no cost-sharing.

 

HHS recently announced an initiative urging medical education organizations to implement “comprehensive nutrition education and training” into their curriculums, in collaboration with the Department of Education. HHS stated the vast majority of physicians graduate with “little to no training in nutrition,” citing research that 75 percent of U.S. medical schools have no required clinical nutrition classes, and only 14 percent of medical residency programs have a required nutrition curriculum. As such, HHS has directed medical education organizations to submit to HHS written plans detailing the “scope, timeline, standards alignment, measurable milestones, and accountability measures” of their nutrition education commitments by September 10. Reforming nutrition education for medical schools has been a priority for Secretary Kennedy under his Make America Healthy Again agenda, with an unofficial draft of the “Make Our Children Healthy Again Strategy” recommending that CMS use its regulatory authorities in this regard.

 

The unofficial draft of the “Make Our Children Health Again Strategy,” action plan was reported by The New York Times on August 14. The reported draft includes several policy recommendations for HHS, many of which have already been circulated by HHS leadership. Initial responses to the reported draft strategy have been mixed, with some indicating that MAHA supporters hoped to see more aggressive policies regarding ultra-processed foods and the agriculture industry.

 

The draft strategy outlines policies addressing four key drivers of poor health outcomes identified by the MAHA Report: Poor Diet, Chemical Exposure, Lack of Physical Activity and Chronic Stress, and Overmedicalization. Specific action items include:

  • Launch a National Institutes of Health (NIH) MAHA Chronic Disease Task Force;
  • Launch a mental health diagnosis and prescription working group to evaluate prescription patterns for selective serotonin reuptake inhibitors (SSRIs), antipsychotics, stimulants, and other relevant drugs for children;
  • Produce a study on electromagnetic radiation and its health impacts;
  • Revise the proposed Front-of-Pack Nutrition labeling rule;
  • Increase Federal Trade Commission (FTC) and Department of Justice (DOJ) oversight of Direct-to-Consumer Pharmaceutical advertising; and
  • Explore enhanced prior authorization requirements to “address the overuse of medications in school-age children.”

The timing for the unveiling of the final strategy has not been announced but could be in the coming weeks.

 

Supreme Court

On August 21, the Supreme Court issued a ruling allowing for HHS to terminate NIH grants that it considers are in violation of executive orders on research related to diversity, equity, and inclusion (DEI) and “gender ideology.” Justice Amy Coney Barrett voted with Justices Clarence Thomas, Samuel Alito, Neil Gorsuch, and Brett Kavanaugh to allow for the termination of grants, but joined Chief Justice John Roberts and Justices Sonia Sotomayor, Elena Kagan, and Ketanji Brown Jackson in voting to uphold a lower court’s decision voiding NIH policies that served as the basis for the grant terminations. The case is one of many related to the Trump Administration’s decisions regarding the staffing, structure, and funding policies of HHS.

 

Open Comment Opportunities, Requests for Information, and Membership Applications

On August 21, HHS and CMS announced the creation of a new Healthcare Advisory Committee, tasked with advising HHS Secretary Robert F. Kennedy, Jr. and CMS Administrator Dr. Mehmet Oz on reforms to improve patient-centered care. The committee will provide strategic recommendations across Medicare, Medicaid, CHIP, and the Health Insurance Marketplace. According to HHS and CMS, the committee’s work will focus on actionable policy initiatives for chronic disease prevention and management, regulatory frameworks to reduce red tape while strengthening accountability, advancing real-time data systems for faster claims and quality reporting, improving care for vulnerable Medicaid populations, and modernizing Medicare Advantage through updated risk adjustment and quality measures. Nominations are open for experts in areas including chronic disease, health care financing, and delivery system reform. Individuals may self-nominate or be nominated by an organization, with submissions due by September 22, 2025.

 

Instructions for submitting nominations, including a cover letter, the nominee’s qualifications, and references can be found on the Federal Register: FR Doc. 2025-16136. Nominations can be submitted by emailing HAC@cms.hhs.gov, with the subject line “Healthcare Advisory Committee Nomination.”

 

The Health Policy Update is an exclusive benefit available to GIH Funding Partners and Philanthropy Support Partners; please do not forward.

 

Grantmakers In Health, 1100 Connecticut Avenue NW, Suite 1100, Washington, DC 20036